Related Experiment Videos
Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction
1Neurologische Klinik und Poliklinik, Georg-August-Universität, Göttingen, Germany.
Abstract:
Using polymerase chain reaction (PCR), 34 cerebrospinal fluid (CSF) samples from 28 patients with progressive multifocal leukoencephalopathy (PML) were analyzed. As controls, 116 samples were evaluated from 82 human immunodeficiency virus type 1 (HIV-1)-infected patients and 1 HIV-1-negative patient. Of the HIV-1-positive patients, 23 had cerebral toxoplasmosis, 10 had HIV leukoencephalopathy, and 49 had other neurologic complications. Detection of JC virus (JCV) DNA in CSF was increased 10-fold by the addition of carrier DNA before phenol-chloroform-isoamyl alcohol extraction. The primer pair JC 26/29, from the VP1/large T region, had a limit of detection of 10(5) JCV DNA molecules/100 microL. The primer pair JC 36/39, located in the large T gene region, had a 100-fold lower limit of detection. With JC 26/29, the sensitivity was 43% (12/28) and specificity was 100%. Using JC 36/39, sensitivity increased to 82% (23/28), and false-positive results were not observed. Diagnosis of PML is greatly aided by PCR analysis of CSF.
Insights
Polymerase chain reaction (PCR) analysis of cerebrospinal fluid (CSF) significantly aids in diagnosing progressive multifocal leukoencephalopathy (PML). A specific primer set (JC 36/39) demonstrated high sensitivity for detecting JC virus (JCV) DNA.
Area of Science:
- Neurovirology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Progressive multifocal leukoencephalopathy (PML) is a serious demyelinating disease of the central nervous system.
- Accurate and timely diagnosis of PML is crucial for patient management, especially in immunocompromised individuals.
- Polymerase chain reaction (PCR) is a valuable tool for detecting viral DNA in cerebrospinal fluid (CSF).
Purpose of the Study:
- To evaluate the diagnostic utility of PCR for detecting JC virus (JCV) DNA in CSF for PML diagnosis.
- To compare the sensitivity and specificity of different primer pairs for JCV DNA detection.
- To assess the impact of carrier DNA addition on JCV DNA detection.
Main Methods:
- Cerebrospinal fluid (CSF) samples from patients with PML and control groups (HIV-1 infected and negative) were analyzed using PCR.
- Two primer pairs, JC 26/29 (VP1/large T region) and JC 36/39 (large T gene region), were used for JCV DNA detection.
- The effect of adding carrier DNA before extraction on JCV DNA detection was investigated.
Main Results:
- Addition of carrier DNA increased JCV DNA detection by 10-fold.
- Primer pair JC 26/29 showed 43% sensitivity and 100% specificity.
- Primer pair JC 36/39 exhibited significantly higher sensitivity (82%) with no false-positive results.
Conclusions:
- PCR analysis of CSF is highly effective in aiding the diagnosis of PML.
- The primer pair JC 36/39 offers superior sensitivity for JCV DNA detection compared to JC 26/29.
- Optimized PCR methods enhance the diagnostic capability for PML, particularly in differentiating it from other neurological conditions in HIV-1 patients.